0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Quetiapine Fumarate Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027
Published Date: August 2021
|
Report Code: QYRE-Auto-9U784
Home | Market Reports | Health | Pharmacy | Drugs & Medications
Global Quetiapine Fumarate Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027

Global Quetiapine Fumarate Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

Code: QYRE-Auto-9U784
Report
August 2021
121 Pages
QYResearch
Region: Global, North America, China, Europe, Japan, France, Germany, Taiwan, Australia, India, South Korea, Indonesia, Thailand, Italy, Saudi Arabia, Turkey, Malaysia, Philippines,
Description
Table of Content
Tables & Figures
Quetiapine Fumarate is an atypical antipsychotic drug used to treat psychiatric disorders such as schizophrenia, bipolar disorder and depression. It may be used alone or in combination with other psychiatric medications. It is taken orally, and is available only by prescription, under the supervision of a medical practitioner.
Europe is the largest Quetiapine Fumarate market with about 92% market share. China is follower, accounting for about 2% market share.
The key players are AstraZeneca, Intas, TAPI, Accord, Hexal, Dr.Reddy's, Lupin, Sun Pharmaceutical, Hunan Dongting Pharm, SuZhou NO.4 Phamaceutical Factory, Fuan Pharmaceutical, Zhejiang Supor Pharmaceuticals, Zhejiang Huahai Pharmaceutical etc. Top 3 companies occupied about 74% market share.
Market Analysis and Insights: Global Quetiapine Fumarate Market

In 2020, the global Quetiapine Fumarate market size was US$ 163.3 million and it is expected to reach US$ 139.8 million by the end of 2027, with a CAGR of -2.2% during 2021-2027.

Global Quetiapine Fumarate Scope and Market Size
Quetiapine Fumarate market is segmented by region, by country, company, type, application and by sales channels. Players, stakeholders, and other participants in the global Quetiapine Fumarate market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region, by country, company, type, application and by sales channels for the period 2016-2027.

Segment by Type, the Quetiapine Fumarate market is segmented into

Immediate Release Tablets
Extended Release Tablets

Segment by Application, the Quetiapine Fumarate market is segmented into

Adult
Others
Regional and Country-level Analysis:
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Competitive Landscape and Quetiapine Fumarate Market Share Analysis
Quetiapine Fumarate market competitive landscape provides details and data information by companies. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2016-2021. It also offers detailed analysis supported by reliable statistics on sale and revenue by players for the period 2016-2021. Details included are company description, major business, Quetiapine Fumarate product introduction, recent developments, Quetiapine Fumarate sales by region, type, application and by sales channel.
The major companies include:
AstraZeneca
Intas
TAPI
Accord
Hexal
Dr.Reddy's
Lupin
Sun Pharmaceutical
Hunan Dongting Pharm
SuZhou NO.4 Phamaceutical Factory
Fuan Pharmaceutical
Zhejiang Supor Pharmaceuticals
Zhejiang Huahai Pharmaceutical
1 Study Coverage
1.1 Quetiapine Fumarate Product Introduction
1.2 Market by Type
1.2.1 Global Quetiapine Fumarate Market Size Growth Rate by Type
1.2.2 Immediate Release Tablets
1.2.3 Extended Release Tablets
1.3 Market by Application
1.3.1 Global Quetiapine Fumarate Market Size Growth Rate by Application
1.3.2 Adult
1.3.3 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Quetiapine Fumarate Market Size Estimates and Forecasts
2.1.1 Global Quetiapine Fumarate Revenue 2016-2027
2.1.2 Global Quetiapine Fumarate Sales 2016-2027
2.2 Quetiapine Fumarate Market Size by Region: 2021 Versus 2027
2.3 Quetiapine Fumarate Sales by Region (2016-2027)
2.3.1 Global Quetiapine Fumarate Sales by Region: 2016-2021
2.3.2 Global Quetiapine Fumarate Sales Forecast by Region (2022-2027)
2.3.3 Global Quetiapine Fumarate Sales Market Share by Region (2016-2027)
2.4 Quetiapine Fumarate Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Quetiapine Fumarate Revenue by Region: 2016-2021
2.4.2 Global Quetiapine Fumarate Revenue Forecast by Region (2022-2027)
2.4.3 Global Quetiapine Fumarate Revenue Market Share by Region (2016-2027)
3 Global Quetiapine Fumarate by Manufacturers
3.1 Global Top Quetiapine Fumarate Manufacturers by Sales
3.1.1 Global Quetiapine Fumarate Sales by Manufacturer (2016-2021)
3.1.2 Global Quetiapine Fumarate Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Quetiapine Fumarate Manufacturers by Revenue
3.2.1 Global Quetiapine Fumarate Revenue by Manufacturer (2016-2021)
3.2.2 Global Quetiapine Fumarate Revenue Share by Manufacturer (2016-2021)
3.3 Global Quetiapine Fumarate Price by Manufacturer (2016-2021)
3.4 Competitive Landscape
3.4.1 Key Quetiapine Fumarate Manufacturers Covered: Ranking by Revenue
3.4.2 Global Quetiapine Fumarate Market Concentration Ratio (CR5 and HHI) & (2016-2021)
3.4.3 Global Quetiapine Fumarate Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Quetiapine Fumarate Manufacturing Base Distribution, Product Type
3.5.1 Quetiapine Fumarate Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Quetiapine Fumarate Product Type
3.5.3 Date of International Manufacturers Enter into Quetiapine Fumarate Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 AstraZeneca
4.1.1 AstraZeneca Corporation Information
4.1.2 AstraZeneca Description, Business Overview
4.1.3 AstraZeneca Quetiapine Fumarate Products Offered
4.1.4 AstraZeneca Quetiapine Fumarate Sales, Revenue and Gross Margin (2016-2021)
4.1.5 AstraZeneca Quetiapine Fumarate Revenue by Product
4.1.6 AstraZeneca Quetiapine Fumarate Revenue by Application
4.1.7 AstraZeneca Quetiapine Fumarate Revenue by Geographic Area
4.1.8 AstraZeneca Quetiapine Fumarate Revenue by Sales Channel
4.1.9 AstraZeneca Recent Development
4.2 Intas
4.2.1 Intas Corporation Information
4.2.2 Intas Description, Business Overview
4.2.3 Intas Quetiapine Fumarate Products Offered
4.2.4 Intas Quetiapine Fumarate Sales, Revenue and Gross Margin (2016-2021)
4.2.5 Intas Quetiapine Fumarate Revenue by Product
4.2.6 Intas Quetiapine Fumarate Revenue by Application
4.2.7 Intas Quetiapine Fumarate Revenue by Geographic Area
4.2.8 Intas Quetiapine Fumarate Revenue by Sales Channel
4.2.9 Intas Recent Development
4.3 TAPI
4.3.1 TAPI Corporation Information
4.3.2 TAPI Description, Business Overview
4.3.3 TAPI Quetiapine Fumarate Products Offered
4.3.4 TAPI Quetiapine Fumarate Sales, Revenue and Gross Margin (2016-2021)
4.3.5 TAPI Quetiapine Fumarate Revenue by Product
4.3.6 TAPI Quetiapine Fumarate Revenue by Application
4.3.7 TAPI Quetiapine Fumarate Revenue by Geographic Area
4.3.8 TAPI Quetiapine Fumarate Revenue by Sales Channel
4.3.9 TAPI Recent Development
4.4 Accord
4.4.1 Accord Corporation Information
4.4.2 Accord Description, Business Overview
4.4.3 Accord Quetiapine Fumarate Products Offered
4.4.4 Accord Quetiapine Fumarate Sales, Revenue and Gross Margin (2016-2021)
4.4.5 Accord Quetiapine Fumarate Revenue by Product
4.4.6 Accord Quetiapine Fumarate Revenue by Application
4.4.7 Accord Quetiapine Fumarate Revenue by Geographic Area
4.4.8 Accord Quetiapine Fumarate Revenue by Sales Channel
4.4.9 Accord Recent Development
4.5 Hexal
4.5.1 Hexal Corporation Information
4.5.2 Hexal Description, Business Overview
4.5.3 Hexal Quetiapine Fumarate Products Offered
4.5.4 Hexal Quetiapine Fumarate Sales, Revenue and Gross Margin (2016-2021)
4.5.5 Hexal Quetiapine Fumarate Revenue by Product
4.5.6 Hexal Quetiapine Fumarate Revenue by Application
4.5.7 Hexal Quetiapine Fumarate Revenue by Geographic Area
4.5.8 Hexal Quetiapine Fumarate Revenue by Sales Channel
4.5.9 Hexal Recent Development
4.6 Dr.Reddy's
4.6.1 Dr.Reddy's Corporation Information
4.6.2 Dr.Reddy's Description, Business Overview
4.6.3 Dr.Reddy's Quetiapine Fumarate Products Offered
4.6.4 Dr.Reddy's Quetiapine Fumarate Sales, Revenue and Gross Margin (2016-2021)
4.6.5 Dr.Reddy's Quetiapine Fumarate Revenue by Product
4.6.6 Dr.Reddy's Quetiapine Fumarate Revenue by Application
4.6.7 Dr.Reddy's Quetiapine Fumarate Revenue by Geographic Area
4.6.8 Dr.Reddy's Recent Development
4.7 Lupin
4.7.1 Lupin Corporation Information
4.7.2 Lupin Description, Business Overview
4.7.3 Lupin Quetiapine Fumarate Products Offered
4.7.4 Lupin Quetiapine Fumarate Sales, Revenue and Gross Margin (2016-2021)
4.7.5 Lupin Quetiapine Fumarate Revenue by Product
4.7.6 Lupin Quetiapine Fumarate Revenue by Application
4.7.7 Lupin Quetiapine Fumarate Revenue by Geographic Area
4.7.8 Lupin Recent Development
4.8 Sun Pharmaceutical
4.8.1 Sun Pharmaceutical Corporation Information
4.8.2 Sun Pharmaceutical Description, Business Overview
4.8.3 Sun Pharmaceutical Quetiapine Fumarate Products Offered
4.8.4 Sun Pharmaceutical Quetiapine Fumarate Sales, Revenue and Gross Margin (2016-2021)
4.8.5 Sun Pharmaceutical Quetiapine Fumarate Revenue by Product
4.8.6 Sun Pharmaceutical Quetiapine Fumarate Revenue by Application
4.8.7 Sun Pharmaceutical Quetiapine Fumarate Revenue by Geographic Area
4.8.8 Sun Pharmaceutical Recent Development
4.9 Hunan Dongting Pharm
4.9.1 Hunan Dongting Pharm Corporation Information
4.9.2 Hunan Dongting Pharm Description, Business Overview
4.9.3 Hunan Dongting Pharm Quetiapine Fumarate Products Offered
4.9.4 Hunan Dongting Pharm Quetiapine Fumarate Sales, Revenue and Gross Margin (2016-2021)
4.9.5 Hunan Dongting Pharm Quetiapine Fumarate Revenue by Product
4.9.6 Hunan Dongting Pharm Quetiapine Fumarate Revenue by Application
4.9.7 Hunan Dongting Pharm Quetiapine Fumarate Revenue by Geographic Area
4.9.8 Hunan Dongting Pharm Recent Development
4.10 SuZhou NO.4 Phamaceutical Factory
4.10.1 SuZhou NO.4 Phamaceutical Factory Corporation Information
4.10.2 SuZhou NO.4 Phamaceutical Factory Description, Business Overview
4.10.3 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Products Offered
4.10.4 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Sales, Revenue and Gross Margin (2016-2021)
4.10.5 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Revenue by Product
4.10.6 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Revenue by Application
4.10.7 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Revenue by Geographic Area
4.10.8 SuZhou NO.4 Phamaceutical Factory Recent Development
4.11 Fuan Pharmaceutical
4.11.1 Fuan Pharmaceutical Corporation Information
4.11.2 Fuan Pharmaceutical Description, Business Overview
4.11.3 Fuan Pharmaceutical Quetiapine Fumarate Products Offered
4.11.4 Fuan Pharmaceutical Quetiapine Fumarate Sales, Revenue and Gross Margin (2016-2021)
4.11.5 Fuan Pharmaceutical Quetiapine Fumarate Revenue by Product
4.11.6 Fuan Pharmaceutical Quetiapine Fumarate Revenue by Application
4.11.7 Fuan Pharmaceutical Quetiapine Fumarate Revenue by Geographic Area
4.11.8 Fuan Pharmaceutical Recent Development
4.12 Zhejiang Supor Pharmaceuticals
4.12.1 Zhejiang Supor Pharmaceuticals Corporation Information
4.12.2 Zhejiang Supor Pharmaceuticals Description, Business Overview
4.12.3 Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Products Offered
4.12.4 Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Sales, Revenue and Gross Margin (2016-2021)
4.12.5 Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Revenue by Product
4.12.6 Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Revenue by Application
4.12.7 Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Revenue by Geographic Area
4.12.8 Zhejiang Supor Pharmaceuticals Recent Development
4.13 Zhejiang Huahai Pharmaceutical
4.13.1 Zhejiang Huahai Pharmaceutical Corporation Information
4.13.2 Zhejiang Huahai Pharmaceutical Description, Business Overview
4.13.3 Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Products Offered
4.13.4 Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Sales, Revenue and Gross Margin (2016-2021)
4.13.5 Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Revenue by Product
4.13.6 Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Revenue by Application
4.13.7 Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Revenue by Geographic Area
4.13.8 Zhejiang Huahai Pharmaceutical Recent Development
5 Breakdown Data by Type
5.1 Global Quetiapine Fumarate Sales by Type (2016-2027)
5.1.1 Global Quetiapine Fumarate Sales by Type (2016-2021)
5.1.2 Global Quetiapine Fumarate Sales Forecast by Type (2022-2027)
5.1.3 Global Quetiapine Fumarate Sales Market Share by Type (2016-2027)
5.2 Global Quetiapine Fumarate Revenue Forecast by Type (2016-2027)
5.2.1 Global Quetiapine Fumarate Revenue by Type (2016-2021)
5.2.2 Global Quetiapine Fumarate Revenue Forecast by Type (2022-2027)
5.2.3 Global Quetiapine Fumarate Revenue Market Share by Type (2016-2027)
5.3 Quetiapine Fumarate Average Selling Price (ASP) by Type (2016-2027)
6 Breakdown Data by Application
6.1 Global Quetiapine Fumarate Sales by Application (2016-2027)
6.1.1 Global Quetiapine Fumarate Sales by Application (2016-2021)
6.1.2 Global Quetiapine Fumarate Sales Forecast by Application (2022-2027)
6.1.3 Global Quetiapine Fumarate Sales Market Share by Application (2016-2027)
6.2 Global Quetiapine Fumarate Revenue Forecast by Application (2016-2027)
6.2.1 Global Quetiapine Fumarate Revenue by Application (2016-2021)
6.2.2 Global Quetiapine Fumarate Revenue Forecast by Application (2022-2027)
6.2.3 Global Quetiapine Fumarate Revenue Market Share by Application (2016-2027)
6.3 Quetiapine Fumarate Average Selling Price (ASP) by Application (2016-2027)
7 North America
7.1 North America Quetiapine Fumarate Market Size YoY Growth 2016-2027
7.2 North America Quetiapine Fumarate Market Facts & Figures by Country
7.2.1 North America Quetiapine Fumarate Sales by Country (2016-2027)
7.2.2 North America Quetiapine Fumarate Revenue by Country (2016-2027)
7.3 North America Quetiapine Fumarate Sales by Type
7.4 North America Quetiapine Fumarate Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific Quetiapine Fumarate Market Size YoY Growth 2016-2027
8.2 Asia-Pacific Quetiapine Fumarate Market Facts & Figures by Region
8.2.1 Asia-Pacific Quetiapine Fumarate Sales by Region (2016-2027)
8.2.2 Asia-Pacific Quetiapine Fumarate Revenue by Region (2016-2027)
8.3 Asia-Pacific Quetiapine Fumarate Sales by Type
8.4 Asia-Pacific Quetiapine Fumarate Sales by Application
9 Europe
9.1 Europe Quetiapine Fumarate Market Size YoY Growth 2016-2027
9.2 Europe Quetiapine Fumarate Market Facts & Figures by Country
9.2.1 Europe Quetiapine Fumarate Sales by Country (2016-2027)
9.2.2 Europe Quetiapine Fumarate Revenue by Country (2016-2027)
9.3 Europe Quetiapine Fumarate Sales by Type
9.4 Europe Quetiapine Fumarate Sales by Application
10 Latin America
10.1 Latin America Quetiapine Fumarate Market Size YoY Growth 2016-2027
10.2 Latin America Quetiapine Fumarate Market Facts & Figures by Country
10.2.1 Latin America Quetiapine Fumarate Sales by Country (2016-2027)
10.2.2 Latin America Quetiapine Fumarate Revenue by Country (2016-2027)
10.3 Latin America Quetiapine Fumarate Sales by Type
10.4 Latin America Quetiapine Fumarate Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa Quetiapine Fumarate Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Quetiapine Fumarate Market Facts & Figures by Country
11.2.1 Middle East and Africa Quetiapine Fumarate Sales by Country (2016-2027)
11.2.2 Middle East and Africa Quetiapine Fumarate Revenue by Country (2016-2027)
11.3 Middle East and Africa Quetiapine Fumarate Sales by Type
11.4 Middle East and Africa Quetiapine Fumarate Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 Quetiapine Fumarate Supply Chain Analysis
12.2 Quetiapine Fumarate Key Raw Materials and Upstream Suppliers
12.3 Quetiapine Fumarate Clients Analysis
12.4 Quetiapine Fumarate Sales Channel and Sales Model Analysis
12.4.1 Quetiapine Fumarate Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Quetiapine Fumarate Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Quetiapine Fumarate Distributors
13 Market Dynamics
13.1 Quetiapine Fumarate Market Drivers
13.2 Quetiapine Fumarate Market Opportunities
13.3 Quetiapine Fumarate Market Challenges
13.4 Quetiapine Fumarate Market Restraints
13.5 Porter’s Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Quetiapine Fumarate Market Size Growth Rate by Type (US$ Million): 2021 VS 2027
    Table 2. Major Manufacturers of Immediate Release Tablets
    Table 3. Major Manufacturers of Extended Release Tablets
    Table 4. Global Quetiapine Fumarate Market Size Growth by Application (US$ Million): 2021 VS 2027
    Table 5. Global Quetiapine Fumarate Market Size by Region (US$ Million): 2021 VS 2027
    Table 6. Global Quetiapine Fumarate Sales by Region (2016-2021) & (MT)
    Table 7. Global Quetiapine Fumarate Sales Forecast by Region (2022-2027) & (MT)
    Table 8. Global Quetiapine Fumarate Revenue by Region (2016-2021) & (US$ Million)
    Table 9. Global Quetiapine Fumarate Revenue Forecast by Region (2022-2027) & (US$ Million)
    Table 10. Global Quetiapine Fumarate Sales by Manufacturer (2016-2021) & (MT)
    Table 11. Global Quetiapine Fumarate Sales Share by Manufacturer (2016-2021)
    Table 12. Quetiapine Fumarate Revenue by Manufacturer (2016-2021) & (US$ Million)
    Table 13. Quetiapine Fumarate Revenue Share by Manufacturer (2016-2021)
    Table 14. Key Manufacturers Quetiapine Fumarate Price (2016-2021) & (USD/Kg)
    Table 15. Ranking of Global Top Quetiapine Fumarate Manufacturers by Revenue (US$ Million) in 2020
    Table 16. Global Quetiapine Fumarate Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
    Table 17. Global Quetiapine Fumarate by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Quetiapine Fumarate as of 2020)
    Table 18. Quetiapine Fumarate Manufacturers Manufacturing Base Distribution and Headquarters
    Table 19. Manufacturers Quetiapine Fumarate Product Type
    Table 20. Date of International Manufacturers Enter into Quetiapine Fumarate Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. AstraZeneca Corporation Information
    Table 23. AstraZeneca Description and Business Overview
    Table 24. AstraZeneca Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
    Table 25. AstraZeneca Quetiapine Fumarate Product
    Table 26. AstraZeneca Quetiapine Fumarate Revenue (US$ Million) and Market Share by Product
    Table 27. AstraZeneca Quetiapine Fumarate Revenue (US$ Million) and Market Share by Application
    Table 28. AstraZeneca Quetiapine Fumarate Revenue (US$ Million) and Market Share by Geographic Area
    Table 29. AstraZeneca Quetiapine Fumarate Revenue (US$ Million) and Market Share by Sales Channel
    Table 30. AstraZeneca Recent Development
    Table 31. Intas Corporation Information
    Table 32. Intas Description and Business Overview
    Table 33. Intas Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
    Table 34. Intas Quetiapine Fumarate Product
    Table 35. Intas Quetiapine Fumarate Revenue (US$ Million) and Market Share by Product
    Table 36. Intas Quetiapine Fumarate Revenue (US$ Million) and Market Share by Application
    Table 37. Intas Quetiapine Fumarate Revenue (US$ Million) and Market Share by Geographic Area
    Table 38. Intas Quetiapine Fumarate Revenue (US$ Million) and Market Share by Sales Channel
    Table 39. Intas Recent Development
    Table 40. TAPI Corporation Information
    Table 41. TAPI Description and Business Overview
    Table 42. TAPI Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
    Table 43. TAPI Quetiapine Fumarate Product
    Table 44. TAPI Quetiapine Fumarate Revenue (US$ Million) and Market Share by Product
    Table 45. TAPI Quetiapine Fumarate Revenue (US$ Million) and Market Share by Application
    Table 46. TAPI Quetiapine Fumarate Revenue (US$ Million) and Market Share by Geographic Area
    Table 47. TAPI Quetiapine Fumarate Revenue (US$ Million) and Market Share by Sales Channel
    Table 48. TAPI Recent Development
    Table 49. Accord Corporation Information
    Table 50. Accord Description and Business Overview
    Table 51. Accord Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
    Table 52. Accord Quetiapine Fumarate Product
    Table 53. Accord Quetiapine Fumarate Revenue (US$ Million) and Market Share by Product
    Table 54. Accord Quetiapine Fumarate Revenue (US$ Million) and Market Share by Application
    Table 55. Accord Quetiapine Fumarate Revenue (US$ Million) and Market Share by Geographic Area
    Table 56. Accord Quetiapine Fumarate Revenue (US$ Million) and Market Share by Sales Channel
    Table 57. Accord Recent Development
    Table 58. Hexal Corporation Information
    Table 59. Hexal Description and Business Overview
    Table 60. Hexal Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
    Table 61. Hexal Quetiapine Fumarate Product
    Table 62. Hexal Quetiapine Fumarate Revenue (US$ Million) and Market Share by Product
    Table 63. Hexal Quetiapine Fumarate Revenue (US$ Million) and Market Share by Application
    Table 64. Hexal Quetiapine Fumarate Revenue (US$ Million) and Market Share by Geographic Area
    Table 65. Hexal Quetiapine Fumarate Revenue (US$ Million) and Market Share by Sales Channel
    Table 66. Hexal Recent Development
    Table 67. Dr.Reddy's Corporation Information
    Table 68. Dr.Reddy's Description and Business Overview
    Table 69. Dr.Reddy's Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
    Table 70. Dr.Reddy's Quetiapine Fumarate Product
    Table 71. Dr.Reddy's Quetiapine Fumarate Revenue (US$ Million) and Market Share by Product
    Table 72. Dr.Reddy's Quetiapine Fumarate Revenue (US$ Million) and Market Share by Application
    Table 73. Dr.Reddy's Quetiapine Fumarate Revenue (US$ Million) and Market Share by Geographic Area
    Table 74. Dr.Reddy's Recent Development
    Table 75. Lupin Corporation Information
    Table 76. Lupin Description and Business Overview
    Table 77. Lupin Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
    Table 78. Lupin Quetiapine Fumarate Product
    Table 79. Lupin Quetiapine Fumarate Revenue (US$ Million) and Market Share by Product
    Table 80. Lupin Quetiapine Fumarate Revenue (US$ Million) and Market Share by Application
    Table 81. Lupin Quetiapine Fumarate Revenue (US$ Million) and Market Share by Geographic Area
    Table 82. Lupin Recent Development
    Table 83. Sun Pharmaceutical Corporation Information
    Table 84. Sun Pharmaceutical Description and Business Overview
    Table 85. Sun Pharmaceutical Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
    Table 86. Sun Pharmaceutical Quetiapine Fumarate Product
    Table 87. Sun Pharmaceutical Quetiapine Fumarate Revenue (US$ Million) and Market Share by Product
    Table 88. Sun Pharmaceutical Quetiapine Fumarate Revenue (US$ Million) and Market Share by Application
    Table 89. Sun Pharmaceutical Quetiapine Fumarate Revenue (US$ Million) and Market Share by Geographic Area
    Table 90. Sun Pharmaceutical Recent Development
    Table 91. Hunan Dongting Pharm Corporation Information
    Table 92. Hunan Dongting Pharm Description and Business Overview
    Table 93. Hunan Dongting Pharm Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
    Table 94. Hunan Dongting Pharm Quetiapine Fumarate Product
    Table 95. Hunan Dongting Pharm Quetiapine Fumarate Revenue (US$ Million) and Market Share by Product
    Table 96. Hunan Dongting Pharm Quetiapine Fumarate Revenue (US$ Million) and Market Share by Application
    Table 97. Hunan Dongting Pharm Quetiapine Fumarate Revenue (US$ Million) and Market Share by Geographic Area
    Table 98. Hunan Dongting Pharm Recent Development
    Table 99. SuZhou NO.4 Phamaceutical Factory Corporation Information
    Table 100. SuZhou NO.4 Phamaceutical Factory Description and Business Overview
    Table 101. SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
    Table 102. SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Product
    Table 103. SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Revenue (US$ Million) and Market Share by Product
    Table 104. SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Revenue (US$ Million) and Market Share by Application
    Table 105. SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Revenue (US$ Million) and Market Share by Geographic Area
    Table 106. SuZhou NO.4 Phamaceutical Factory Recent Development
    Table 107. Fuan Pharmaceutical Corporation Information
    Table 108. Fuan Pharmaceutical Description and Business Overview
    Table 109. Fuan Pharmaceutical Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
    Table 110. Fuan Pharmaceutical Quetiapine Fumarate Product
    Table 111. Fuan Pharmaceutical Quetiapine Fumarate Revenue (US$ Million) and Market Share by Product
    Table 112. Fuan Pharmaceutical Quetiapine Fumarate Revenue (US$ Million) and Market Share by Application
    Table 113. Fuan Pharmaceutical Quetiapine Fumarate Revenue (US$ Million) and Market Share by Geographic Area
    Table 114. Fuan Pharmaceutical Recent Development
    Table 115. Zhejiang Supor Pharmaceuticals Corporation Information
    Table 116. Zhejiang Supor Pharmaceuticals Description and Business Overview
    Table 117. Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
    Table 118. Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Product
    Table 119. Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Revenue (US$ Million) and Market Share by Product
    Table 120. Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Revenue (US$ Million) and Market Share by Application
    Table 121. Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Revenue (US$ Million) and Market Share by Geographic Area
    Table 122. Zhejiang Supor Pharmaceuticals Recent Development
    Table 123. Zhejiang Huahai Pharmaceutical Corporation Information
    Table 124. Zhejiang Huahai Pharmaceutical Description and Business Overview
    Table 125. Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
    Table 126. Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Product
    Table 127. Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Revenue (US$ Million) and Market Share by Product
    Table 128. Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Revenue (US$ Million) and Market Share by Application
    Table 129. Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Revenue (US$ Million) and Market Share by Geographic Area
    Table 130. Zhejiang Huahai Pharmaceutical Recent Development
    Table 131. Global Quetiapine Fumarate Sales by Type (2016-2021) & (MT)
    Table 132. Global Quetiapine Fumarate Sales Forecast by Type (2022-2027) & (MT)
    Table 133. Global Quetiapine Fumarate Revenue by Type (2016-2021) & (US$ Million)
    Table 134. Global Quetiapine Fumarate Revenue Forecast by Type (2022-2027) & (US$ Million)
    Table 135. Global Quetiapine Fumarate Sales by Application (2016-2021) & (MT)
    Table 136. Global Quetiapine Fumarate Sales Forecast by Application (2022-2027) & (MT)
    Table 137. Global Quetiapine Fumarate Revenue by Application (2016-2021) & (US$ Million)
    Table 138. Global Quetiapine Fumarate Revenue Forecast by Application (2022-2027) & (US$ Million)
    Table 139. North America Quetiapine Fumarate Sales by Country (2016-2021) & (MT)
    Table 140. North America Quetiapine Fumarate Sales by Country (2022-2027) & (MT)
    Table 141. North America Quetiapine Fumarate Revenue by Country (2016-2021) & (US$ Million)
    Table 142. North America Quetiapine Fumarate Revenue by Country (2022-2027) & (US$ Million)
    Table 143. North America Quetiapine Fumarate Sales by Type (2016-2021) & (MT)
    Table 144. North America Quetiapine Fumarate Sales by Application (2016-2021) & (MT)
    Table 145. Asia-Pacific Quetiapine Fumarate Sales by Region (2016-2021) & (MT)
    Table 146. Asia-Pacific Quetiapine Fumarate Sales by Region (2022-2027) & (MT)
    Table 147. Asia-Pacific Quetiapine Fumarate Revenue by Region (2016-2027) & (US$ Million)
    Table 148. Asia-Pacific Quetiapine Fumarate Revenue by Region (2022-2027) & (US$ Million)
    Table 149. Asia-Pacific Quetiapine Fumarate Sales by Type (2016-2021) & (MT)
    Table 150. Asia-Pacific Quetiapine Fumarate Sales by Application (2016-2021) & (MT)
    Table 151. Europe Quetiapine Fumarate Sales by Country (2016-2021) & (MT)
    Table 152. Europe Quetiapine Fumarate Sales by Country (2022-2027) & (MT)
    Table 153. Europe Quetiapine Fumarate Revenue by Country (2016-2021) & (US$ Million)
    Table 154. Europe Quetiapine Fumarate Revenue by Country (2022-2027) & (US$ Million)
    Table 155. Europe Quetiapine Fumarate Sales by Type (2016-2021) & (MT)
    Table 156. Europe Quetiapine Fumarate Sales by Application (2016-2021) & (MT)
    Table 157. Latin America Quetiapine Fumarate Sales by Country (2016-2021) & (MT)
    Table 158. Latin America Quetiapine Fumarate Sales by Country (2022-2027) & (MT)
    Table 159. Latin America Quetiapine Fumarate Revenue by Country (2016-2021) & (US$ Million)
    Table 160. Latin America Quetiapine Fumarate Revenue by Country (2022-2027) & (US$ Million)
    Table 161. Latin America Quetiapine Fumarate Sales by Type (2016-2021) & (MT)
    Table 162. Latin America Quetiapine Fumarate Sales by Application (2016-2021) & (MT)
    Table 163. Middle East and Africa Quetiapine Fumarate Sales by Country (2016-2021) & (MT)
    Table 164. Middle East and Africa Quetiapine Fumarate Sales by Country (2022-2027) & (MT)
    Table 165. Middle East and Africa Quetiapine Fumarate Revenue by Country (2016-2021) & (US$ Million)
    Table 166. Middle East and Africa Quetiapine Fumarate Revenue by Country (2022-2027) & (US$ Million)
    Table 167. Middle East and Africa Quetiapine Fumarate Sales by Type (2016-2021) & (MT)
    Table 168. Middle East and Africa Quetiapine Fumarate Sales by Application (2016-2021) & (MT)
    Table 169. Quetiapine Fumarate Key Raw Materials, Industry Status and Trend
    Table 170. Quetiapine Fumarate Key Raw Materials and Upstream Suppliers
    Table 171. Quetiapine Fumarate Clients Status and Trend
    Table 172. Quetiapine Fumarate Typical Clients
    Table 173. Quetiapine Fumarate Distributors
    Table 174. Key Drivers: Impact Analysis (2022-2027)
    Table 175. Quetiapine Fumarate Market Drivers
    Table 176. Quetiapine Fumarate Market Opportunities
    Table 177. Quetiapine Fumarate Market Challenges
    Table 178. Quetiapine Fumarate Market Restraints
    Table 179. Quetiapine Fumarate Porter’s Five Forces Analysis
    Table 180. Research Programs/Design for This Report
    Table 181. Key Data Information from Secondary Sources
    Table 182. Key Data Information from Primary Sources
List of Figures
    Figure 1. Quetiapine Fumarate Product Picture
    Figure 2. Global Quetiapine Fumarate Sales Market Share by Type in 2021 & 2027
    Figure 3. Immediate Release Tablets Product Picture
    Figure 4. Extended Release Tablets Product Picture
    Figure 5. Global Quetiapine Fumarate Sales Market Share by Application in 2021 & 2027
    Figure 6. Adult Examples
    Figure 7. Others Examples
    Figure 8. Quetiapine Fumarate Report Years Considered
    Figure 9. Global Quetiapine Fumarate Market Size, (US$ Million), 2016 VS 2021 VS 2027
    Figure 10. Global Quetiapine Fumarate Market Size 2016-2027 (US$ Million)
    Figure 11. Global Quetiapine Fumarate Sales 2016-2027 (K Units)
    Figure 12. Global Quetiapine Fumarate Market Size Market Share by Region: 2021 Versus 2027
    Figure 13. Global Quetiapine Fumarate Sales Market Share Forecast by Region (2016-2027)
    Figure 14. Global Quetiapine Fumarate Revenue Market Share by Region (2016-2027)
    Figure 15. Global Quetiapine Fumarate Sales Share by Manufacturer in 2020
    Figure 16. Quetiapine Fumarate Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
    Figure 17. Global Quetiapine Fumarate Sales Market Share Forecast by Type (2016-2027)
    Figure 18. Global Quetiapine Fumarate Revenue Market Share Forecast by Type (2016-2027)
    Figure 19. Quetiapine Fumarate Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit)
    Figure 20. Global Quetiapine Fumarate Sales Market Share Forecast by Application (2016-2027)
    Figure 21. Global Quetiapine Fumarate Revenue Market Share Forecast by Application (2016-2027)
    Figure 22. Quetiapine Fumarate Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit)
    Figure 23. North America Quetiapine Fumarate Revenue 2016-2027 (US$ Million)
    Figure 24. North America Quetiapine Fumarate Sales Market Share by Type (2016-2021)
    Figure 25. North America Quetiapine Fumarate Sales Market Share by Application (2016-2021)
    Figure 26. Asia-Pacific Quetiapine Fumarate Revenue 2016-2027 (US$ Million)
    Figure 27. Asia-Pacific Quetiapine Fumarate Sales Market Share by Region (2016-2027)
    Figure 28. Asia-Pacific Quetiapine Fumarate Revenue Market Share by Region (2016-2027)
    Figure 29. Asia-Pacific Quetiapine Fumarate Sales Market Share by Type (2016-2021)
    Figure 30. Asia-Pacific Quetiapine Fumarate Sales Market Share by Application (2016-2021)
    Figure 31. Europe Quetiapine Fumarate Revenue Growth Rate 2016-2027 (US$ Million)
    Figure 32. Europe Quetiapine Fumarate Sales Market Share by Country (2016-2027)
    Figure 33. Europe Quetiapine Fumarate Revenue Market Share by Country (2016-2027)
    Figure 34. Europe Quetiapine Fumarate Sales Market Share by Type (2016-2021)
    Figure 35. Europe Quetiapine Fumarate Sales Market Share by Application (2016-2021)
    Figure 36. Latin America Quetiapine Fumarate Revenue Growth Rate 2016-2027 (US$ Million)
    Figure 37. Latin America Quetiapine Fumarate Sales Market Share by Country (2016-2027)
    Figure 38. Latin America Quetiapine Fumarate Revenue Market Share by Country (2016-2021)
    Figure 39. Latin America Quetiapine Fumarate Sales Market Share by Type (2016-2021)
    Figure 40. Latin America Quetiapine Fumarate Sales Market Share by Application (2016-2021)
    Figure 41. Middle East and Africa Quetiapine Fumarate Revenue Growth Rate 2016-2027 (US$ Million)
    Figure 42. Middle East and Africa Quetiapine Fumarate Sales Market Share by Country (2016-2027)
    Figure 43. Middle East and Africa Quetiapine Fumarate Revenue Market Share by Country (2016-2027)
    Figure 44. Middle East and Africa Quetiapine Fumarate Sales Market Share by Type (2016-2021)
    Figure 45. Middle East and Africa Quetiapine Fumarate Sales Market Share by Application (2016-2021)
    Figure 46. Quetiapine Fumarate Supply Chain (Upstream and Downstream Market)
    Figure 47. Global Production Market Share of Quetiapine Fumarate Raw Materials by Region in 2020
    Figure 48. Quetiapine Fumarate Distribution Channels
    Figure 49. Global Quetiapine Fumarate Percentage 2016-2027: Indirect Sales VS Direct Sales
    Figure 50. Global Quetiapine Fumarate Percentage 2016-2027: Online Sales VS Offline Sales
    Figure 51. Porter's Five Forces Analysis
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation
    Figure 54. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$5900
This license allows only one user(purchaser of the report) to access the PDF.

Electronic (PDF)
$8850
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$11800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
SIS Group of Schools

RELATED REPORTS

Global and China Prophylactic HIV Drug Market Insights Forecast to 2027
Global and China Prophylactic HIV Drug Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-7T7637
Sun Nov 21 00:00:00 UTC 2021

Add to Cart

Global and United States Heparin Injection Market Insights Forecast to 2027
Global and United States Heparin Injection Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-37T7287
Sat Nov 20 00:00:00 UTC 2021

Add to Cart

Global and United States Chemotherapy Infusion Set Market Insights Forecast to 2027
Global and United States Chemotherapy Infusion Set Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-25T7219
Sat Nov 20 00:00:00 UTC 2021

Add to Cart

Global and Japan Joint Pain Injections Market Insights Forecast to 2027
Global and Japan Joint Pain Injections Market Insights, Forecast to 2027

Based on distribution channel the market has been segregated into hospital pharmacies retail pharmacies and online pharmacies.Market Analysis and Insights Global and Japan Joint Pain Injections MarketThis report focuses on global and Japan Joint Pain Injections market.In 2020 the global Joint Pain Injections market size was US 2768.5 million and it is expected to reach US 4013.6 million by the end of 2027 with a CAGR of 5.0 during 20212027.

120 Pages
Type: Report
Code: QYRE-Auto-21F7416
Sat Nov 20 00:00:00 UTC 2021

Add to Cart